Phase
Condition
N/ATreatment
mineral trioxide aggregate (MTA)
Biodentine
Clinical Study ID
Ages 2-12 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female patients ages of 2 to ≤12 years.
Bilateral symptomatic or asymptomatic vital primary molars with caries approximatingor into the pulp.
Patient who need a pulpotomy and/or indirect pulp cap treatments in two or morequadrants.
Parents of patients who can provide consent in English.
Patients who need treatment in an operating room setting at Geisinger.
Exclusion
Exclusion Criteria:
Pre-operative radiographic or clinical symptoms associated with irreversiblepulpitis or necrotic pulp.
Radiographs not displaying furcation region of the tooth.
Patients with cardiac conditions who need prophylaxis for infective Endocarditis.
Patients with any type of cancer in the past or present.
Non-restorable molars.
Study Design
Study Description
Connect with a study center
Geisinger
Danville, Pennsylvania 17822
United StatesActive - Recruiting


Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.